Home/Filings/4/0001209191-22-038762
4//SEC Filing

Walsh Colin 4

Accession 0001209191-22-038762

CIK 0001783032other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 6:45 PM ET

Size

5.4 KB

Accession

0001209191-22-038762

Insider Transaction Report

Form 4
Period: 2022-06-17
Walsh Colin
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-17+15,61915,619 total
    Exercise: $1.31Exp: 2032-06-16Common Stock (15,619 underlying)
Footnotes (1)
  • [F1]The entire award will vest on the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on such date.

Issuer

Elevation Oncology, Inc.

CIK 0001783032

Entity typeother

Related Parties

1
  • filerCIK 0001866174

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 6:45 PM ET
Size
5.4 KB